EW LEGAL NOTICE: Edwards Lifesciences Investors are Notified to …

1 day ago · New York, New York--(Newsfile Corp. - November 13, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation ...

CouponFollow Extension

$407
OFF

Edwards - Overview, News & Similar Companies | ZoomInfo.com

2 weeks from now

Aug 5, 2024 · SMC Corporation of America. 1,500. $407.4M. 4. Watson-Marlow Fluid Technology... 1,750. $412.6M. 5. Norgren. 5,940. $1.6B. 6. See more similar companies. View …

zoominfo.com

FAQs about EW LEGAL NOTICE: Edwards Lifesciences Investors are Notified to … Coupon?

Did Edwards Lifesciences violate federal securities laws?

New York, New York-- (Newsfile Corp. - November 13, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE: EW) and certain of the Company's senior executives for potential violations of the federal securities laws. ...

When can investors file a complaint against Edwards Lifesciences?

Investors have until December 13, 2024 to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10 (b) and 20 (a) of the Securities Exchange Act of 1934 on behalf of investors in Edwards Lifesciences securities. ...

What if I invested in Edwards Lifesciences?

If you invested in Edwards Lifesciences you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. ...

Who is Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation, et al., No. 24-cv-02221. What is the Lawsuit About? The Complaint alleges that Edwards is an international company that researches, develops, and provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions. ...

What is Patel v Edwards Lifesciences Corporation?

The complaint asserts claims under Sections 10 (b) and 20 (a) of the Securities Exchange Act of 1934 on behalf of investors in Edwards Lifesciences securities. The case is pending in the U.S. District Court for the Central District of California and is captioned Patel v. Edwards Lifesciences Corporation, et al., No. 24-cv-02221. ...

Does Edwards Lifesciences own Becton Dickinson?

Edwards Lifesciences NYSE:EW on Monday said it has agreed to sell its critical care products unit to Becton Dickinson NYSE:BDX in an all-cash transaction valued at $4.2 billion. With this agreement, California-based Edwards said it is no longer pursuing the previously announced spin-off of the crit… ...